Common Targeted Therapies in Acute Leukaemia’s Requiring Modification of Practice in Hematopathology

In recent years, advancements in the therapeutics of acute leukemias have particularly focused on targeted therapy. Therapy against several immunophenotypic and molecular targets has become the standard of care. Pathologists need to stay informed and modify practices accordingly to support the implementation of these therapies. Here, we discuss some of the common therapeutic targets and corresponding best pathology practices in acute Leukemia.